Search
for
Sort by
Research 481–510 of 942
- Alopecia areata – Current understanding and management
- The burden of alopecia areata: A scoping review focusing on quality of life, mental health and work productivity
- Frontal Fibrosing Alopecia Quality of Life Index: A Validated Disease-Specific Questionnaire Involving Women
- Beyond health-related quality of life: initial psychometric validation of a new scale for addressing the gap in assessing the full range of alopecia areata psychosocial burden
- Diagnostic Accuracy of Trichoscopy in Trichotillomania: A Systematic Review
- Using qualitative methods to establish the clinically meaningful threshold for treatment success in alopecia areata
- Treatment options and emotional well-being in patients with rosacea: An unsupervised machine learning analysis of over 200,000 posts
- Gender-Difference in Hair Length as Revealed by Crispr-Based Production of Long-Haired Mice with Dysfunctional FGF5 Mutations
- Baricitinib for the Treatment of Alopecia Areata
- II Consensus of the Brazilian Society of Dermatology for the treatment of alopecia areata
- Case report: Psoriasiform eczema with immune-mediated comorbidities treated with upadacitinib
- Childhood Alopecia Areata: An Overview of Treatment and Recent Patents
- Eyebrow Restoration in Deep Facial Burn: Follicular Unit Extraction Hair Transplantation after Nanofat Graft
- Minimally Invasive Removal of Leukotrichia and Hair Transplantation: A 2-Step Surgery in the Treatment of Stable Follicular Vitiligo
- Efficacy of Upadacitinib in Treating Alopecia Areata, Atopic Dermatitis, and Th1 Comorbidities in Pediatric Patients: A Comprehensive Case Series and Literature Review
- Raising awareness of Demodex mites: a neglected cause of skin disease
- Cytokine-Targeting Biologic Therapies for Alopecia Areata: A Comprehensive Review of Mechanism of Action, Clinical Efficacy, and Adverse Events
- 51840 Efficacy of the Oral JAK1/JAK2 Inhibitor Deuruxolitinib in Adult Patients with Moderate to Severe Alopecia Areata: Pooled Results from the Multinational Double-Blind, Placebo-Controlled THRIVE-AA1 and THRIVE-AA2 Phase 3 Trials
- Drug-induced scarring and permanent alopecia
- Reversing Gray Hair: Inspiring the Development of New Therapies Through Research on Hair Pigmentation and Repigmentation Progress
- Ritlecitinib for Severe Alopecia Areata: A 24-Week, Multicentre, Real-World Study
- Alopecia areata: A clinical review of the changing landscape with Janus kinase inhibitors
- Menopause and hair loss in women: Exploring the hormonal transition
- The first 20 years of skin of color dermatology: An era of advancements in skin, hair, and nail disorders
- Frontal Fibrosing Alopecia and Reproductive Health: Assessing the Role of Sex Hormones in Disease Development
- Treatments for Moderate-to-Severe Alopecia Areata: A Systematic Narrative Review
- Efficacy of Baricitinib in Patients with Various Degrees of Alopecia Areata Severity: Post-Hoc Analysis from BRAVE AA1 and BRAVE AA2
- Alopecia Areata: Burden of Disease, Approach to Treatment, and Current Unmet Needs
- Type 2 Diabetes Mellitus and Demodex folliculorum Infestation: A Cross-Sectional Study in Peruvian Patients
- Management of Alopecia Due to Cancer Therapies